Stock NATCOPHARM NATCO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 06:02:13 2024-04-26 am EDT 		5-day change 1st Jan Change
1,028 INR +0.66% Intraday chart for NATCO Pharma Limited +2.85% +26.69%
Apr. 09 Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit MT
Mar. 27 NATCO Pharma Limited Announces Board Appointments CI

Business Summary

Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with focus on research and development. The Company is engaged in in the development, manufacturing and commercialization of complex pharmaceuticals that target specific therapeutic areas. It specializes in catering to niche markets and offering solutions to address complex medical needs. It owns nine manufacturing facilities across India and two research centers in Telangana. The Company’s segment includes Pharmaceuticals and Agro chemicals. Its Pharmaceuticals segment is engaged in manufacturing and selling of bulk drugs, finished dosage formulations and related services. Its Agro Chemicals is engaged in manufacturing and selling of agro chemical. It manufactures active pharmaceutical ingredients products which are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe, and United States of America.

Number of employees: 3,946

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
98.5 %
19,399 99.7 % 26,662 98.5 % +37.44%
Agro Chemicals
1.5 %
49 0.3 % 409 1.5 % +734.69%

Sales per region

INR in Million2022Weight2023Weight Delta
United States
59.3 %
9,782 50.3 % 16,060 59.3 % +64.18%
Rest of the World
22.2 %
3,576 18.4 % 5,997 22.2 % +67.70%
India
18.5 %
6,090 31.3 % 5,014 18.5 % -17.67%

Managers

Managers TitleAgeSince
Rajeev Nannapaneni CEO
 Chief Executive Officer 46 00-07-02
Venkaiah Chowdary Nannapaneni FOU
 Founder 78 81-09-18
S. V. V. N. Appa Rao DFI
 Director of Finance/CFO - -
Sanivarapu RaviPrakash Reddy COO
 Chief Operating Officer - -
Venkat Ramesh Chekuri CMP
 Compliance Officer - 22-03-31
M. Pulla Reddy CTO
 Chief Tech/Sci/R&D Officer 66 94-03-31
Donthineni Linga Rao CTO
 Chief Tech/Sci/R&D Officer 71 93-02-10
Pavan Ganapati Bhat BRD
 Director/Board Member - -
P. S. R. K. Prasad BRD
 Director/Board Member 66 14-11-11
Sadasiva N. Rao LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Venkaiah Chowdary Nannapaneni FOU
 Founder 78 81-09-18
Rajeev Nannapaneni CEO
 Chief Executive Officer 46 00-07-02
T. Venkateswara Rao BRD
 Director/Board Member 70 14-04-17
Leela Digumarti BRD
 Director/Board Member - 14-09-21
M. U. R Naidu BRD
 Director/Board Member 74 15-02-10
Donthineni Linga Rao CTO
 Chief Tech/Sci/R&D Officer 71 93-02-10
P. S. R. K. Prasad BRD
 Director/Board Member 66 14-11-11
Pavan Ganapati Bhat BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 179,109,870 83,757,134 ( 46.76 %) 0 46.76 %

Shareholders

NameEquities%Valuation
Venkaiah Chowdary Nannapaneni
15.66 %
28,045,905 15.66 % 320 M ₹
Time Cap Pharma Labs Pvt Ltd.
9.589 %
17,175,420 9.589 % 196 M ₹
Venkata Satya Swathi Kantamani
8.924 %
15,983,340 8.924 % 182 M ₹
Natsoft Information Systems Pvt Ltd.
8.813 %
15,784,900 8.813 % 180 M ₹
Life Insurance Corporation of India (Investment Portfolio)
4.115 %
7,370,212 4.115 % 84 M ₹
Neelima Sita Nannapaneni
2.382 %
4,265,710 2.382 % 49 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
2.171 %
3,889,071 2.171 % 44 M ₹
Durga Devi Nannapaneni
1.976 %
3,539,100 1.976 % 40 M ₹
Tata Asset Management Ltd.
0.9101 %
1,630,000 0.9101 % 19 M ₹
Kotak Mahindra Life Insurance Co., Ltd.
0.7730 %
1,384,499 0.7730 % 16 M ₹

Company contact information

NATCO Pharma Ltd.

NATCO House Road No. 2

500034, Hyderabad

+91 40 2354 7532

http://www.natcopharma.co.in
address NATCO Pharma Limited(NATCOPHARM)

Group companies

NameCategory and Sector
Natco Pharma (Canada), Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for NATCO Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
1,021 INR
Average target price
975.4 INR
Spread / Average Target
-4.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NATCO PHARMA LIMITED Stock NATCO Pharma Limited
+27.33% 2.2B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.77% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.10% 233B
NOVARTIS AG Stock Novartis AG
+5.47% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-10.10% 193B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 143B
AMGEN INC. Stock Amgen Inc.
-6.47% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NATCOPHARM Stock
  4. Company NATCO Pharma Limited